Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
19 drug approvals in 2024 that had 'big clinical impact,' according to GoodRx
GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...
Hosted on MSN1mon
The growing list of conditions weight-loss drugs could help with
Ozempic and similar weight loss drugs have been hailed as a boon for ... Ozempic was linked to a lower risk of getting diagnosed with Alzheimer's among people with type 2 diabetes in a large ...
STAT11d
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
Hosted on MSN2mon
Common cholesterol drug slows mental decline from Alzheimer's disease
Related Stories 'Wonder Drug' statins may provide protection against depression Can ultrasound help treat Alzheimer’s, Dementia and ... this is not an exhaustive list of all statins available.
Neurology Advisor11d
Reduce Risk of Dementia by Combining Cardiovascular Disease Drug Classes
Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.
WebMD29d
Safety Precautions for People with Alzheimer’s
Alzheimer’s disease is a progressive condition ... Keep a current list of prescribed and over-the-counter medications and dosages to share with all your loved one’s health care providers.
Forbes2mon
UK’s NICE Says Alzheimer’s Disease Drug Kisunla Is Not Cost-Effective
The United Kingdom medicines authority approved the Alzheimer’s disease drug Kisunla (donanemab) last week for certain patients. This follows the Unites States Food and Drug Administration ...
Forbes8mon
Medicare Says It Expects To Spend $3.5 Billion In 2025 On Alzheimer’s Drug Leqembi, But This Is Unlikely
Plaque accretion is hypothesized to be a cause of Alzheimer’s. It’s also important to note that CMS estimates are well beyond what the drug’s sponsors, Eisai and Biogen, have forecast ...
Nottingham Post29d
Warning over medication that could increase risk of dementia
New research indicates that medication used by hundreds of thousands in the UK could heighten the risk of dementia. Anticholinergics, prescribed to alleviate over-active bladders, work by reducing ...
Dallas Innovates1d
Alpha Cognition Inks $44M Licensing Agreement With China’s CMS for Alpha’s ZUNVEYL Alzheimer’s Drug
The agreement with China Medical System Holdings Limited is for the development, manufacturing, and commercialization of ...
Reuters1mon
CervoMed's dementia drug fails mid-stage trial, shares slump
The drug, neflamapimod, did not achieve the trial's main goal of significantly reducing symptoms of dementia versus a placebo, but the company said it believed the treatment had potential and ...